Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-30
2007-01-30
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S324000, C530S325000, C530S326000
Reexamination Certificate
active
10478987
ABSTRACT:
The invention concerns the use of hepcidin for the diagnosis and therapy of disorders of iron homeostasis. Hepcidin can be used in the treatment of disorders resulting from iron overload, while inhibitors of hepcidin can he used in the treatment of anaemia.
REFERENCES:
Hemochromatosis. The Mayo Clinic. Sep. 14, 2004. 7 pages.
Anemia. The Mayo Clinic. Feb. 23, 2005. 7 pages.
Hemochromatosis. [internet document] Updated Sep. 14, 2004, accessed Sep. 22, 2005, 10 pages. <http://www.ohiohealth.com/healthreference/reference/992CA155-2D99-4C3E-BDBF4F4470FE5B8F.htm?category=disease>.
(What is hemochromatosis? Clevland Clinic Journal of Medicine (2002) 69(3), p. 238.
S. Rivera, et al. Blood (2005) 106(6), pp. 2196-2199.
“Type I diabetes” updated Sep. 24, 2004, accessed Sep. 23, 2005, <http://www.netdoctor.co.uk/diseases/facts/diabetesinsulinindependent.htm>, 4 pages.
E. Berlin “Hypertrophic Cardiomyopathy” <http://www.healthopedia.com/hypertrophic-cardiomyopathy/prevention.html>, reviewed Jul. 3, 2001, accessed Sep. 23, 2005, 1 page.
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
D. Voet and J.G. Voet. Biochemistry, 2nd Edition.(1995), pp. 235-241.
D.E. Smilek, et al. Proc. Natl. Acad. Sci. USA (1991) 88, pp. 9633-9637.
W.S. Messer, “Vasopressin and Oxytocin”, [web document] updated Apr. 3, 2000; http://www.neurosci.pharm.utoledo.edu/MBC3320/vasopressin.htm; 5 pages.
S. Rivera, et al. Blood (2005) 106(6) pp. 2196-2199.
Christelle Pigeon, et al. “A New Mouse Live-Specific Gene, Encoding A Protein Homologous To Human Antimicrobial Peptide Hepcidin, Is Overexpressed During Iron Overload.”Journal of Biological Chemistry. vol. 276, No. 11, Mar. 2001, pp. 7811-7819.
Christina H. Park, et al. “Hepcidin, A Urinary Antimicrobial Peptide Synthesized In The Liver.”Journal of Biological Chemistry. vol. 276, No. 11, Mar. 2001, pp. 7806-7810.
Alexander Krause, et al. “LEAP-1, A Novel Highly Disulfide-bonded Human Peptide, Exhibits Antimicrobial Activity.”FEBS Letters, Elsevier Science Publishers. vol. 480, No. 2-3, Sep. 2000, pp. 147-150.
Gaël Nicolas, et al. “Severe Iron Deficiency Anemia In Transgenic Mice Expressing Liver Hepcidin.”Proceedings of the National Academy of Sciences of the United States. vol. 99, No. 7, Apr. 2002, pp. 4596-4601.
Gaël Nicolas, et al. “Lack of Hepcidin Gene Expression and Severe Tissue Iron Overload in Upstream Stimulatory Factor 2 (USF2) Knockout Mice.”Proceedings of the National Academy of Sciences of the United States. vol. 98, No. 15, Jul. 2001, pp. 8780-8785.
Robert Fleming, et al. “Hepcidin: A Putative Iron-Regulatory Hormone Relevant To Hereditary Hemochromatosis and the Anemia of Chronic Disease.”Proceedings of the National Academy of the Sciences of the United States. vol. 98, No. 15, Jul. 2001, pp. 8160-8162.
Kahn Axel
Nicolas Gaël
Vaulont Sophie
Institut National de la Sante et de la Recherche Medicale (Inser
Kosar Andrew D.
Morgan & Lewis & Bockius, LLP
Tsang Cecilia J.
LandOfFree
Use of hepcidin as a regulator of iron homeostasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hepcidin as a regulator of iron homeostasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hepcidin as a regulator of iron homeostasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791465